Abstract
This protocol details a procedure, known as the modified preplate technique, which is currently used in our laboratory to isolate muscle cells on the basis of selective adhesion to collagen-coated tissue culture plates. By employing this technique to murine skeletal muscle, we have been able to isolate a rapidly adhering cell (RAC) fraction within the earlier stages of the process, whereas a slowly adhering cell (SAC) fraction containing muscle-derived stem cells is obtained from the later stages of the process. This protocol outlines the methods and materials needed to isolate RAC and SAC populations from murine skeletal muscle. The procedure involves mechanical and enzymatic digestion of skeletal muscle tissue with collagenase XI, dispase and trypsin followed by plating the resultant muscle slurry on collagen type I-coated flasks where the cells adhere at different rates. The entire preplate technique requires 5 d to obtain the final preplate SAC population. Two to three additional days are usually required before this population is properly established. We also detail additional methodologies designed to further enrich the resultant cell population by continuing the modified preplating process on the SAC population. This process is known as replating and requires further time.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kessler, P.D. & Byrne, B.J. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu. Rev. Physiol. 61, 219–242 (1999).
Marelli, D., Desrosiers, C., el-Alfy, M., Kao, R.L. & Chiu, R.C. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. 1, 383–390 (1992).
Reinecke, H., Poppa, V. & Murry, C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol. 34, 241–249 (2002).
Suzuki, K. et al. Development of a novel method for cell transplantation through the coronary artery. Circulation 102, III359–III364 (2000).
Taylor, D.A. et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4, 929–933 (1998).
Dib, N. et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant. 14, 11–19 (2005).
Dib, N. et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112, 1748–1755 (2005).
Herreros, J. et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24, 2012–2020 (2003).
Ince, H., Petzsch, M., Rehders, T.C., Chatterjee, T. & Nienaber, C.A. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J. Endovasc. Ther. 11, 695–704 (2004).
Menasche, P. Cellular transplantation: hurdles remaining before widespread clinical use. Curr. Opin. Cardiol. 19, 154–161 (2004).
Menasche, P. Myoblast transfer in heart failure. Surg. Clin. North Am. 84, 125–139 (2004).
Menasche, P. Skeletal myoblast for cell therapy. Coron. Artery Dis. 16, 105–110 (2005).
Menasche, P. et al. Myoblast transplantation for heart failure. Lancet 357, 279–280 (2001).
Menasche, P. et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41, 1078–1083 (2003).
Pagani, F.D. et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41, 879–888 (2003).
Smits, P.C. et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42, 2063–2069 (2003).
Beauchamp, J.R., Morgan, J.E., Pagel, C.N. & Partridge, T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144, 1113–1122 (1999).
Fan, Y., Maley, M., Beilharz, M. & Grounds, M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19, 853–860 (1996).
Guerette, B., Asselin, I., Skuk, D., Entman, M. & Tremblay, J.P. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant. 6, 101–107 (1997).
Gussoni, E., Blau, H.M. & Kunkel, L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3, 970–977 (1997).
Gussoni, E. et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356, 435–438 (1992).
Huard, J., Acsadi, G., Jani, A., Massie, B. & Karpati, G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5, 949–958 (1994).
Huard, J. et al. Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin. Sci. 81, 287–288 (1991).
Huard, J. et al. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 15, 550–560 (1992).
Huard, J. et al. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant. Proc. 24, 3049–3051 (1992).
Huard, J. et al. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 17, 224–234 (1994).
Huard, J., Verreault, S., Roy, R., Tremblay, M. & Tremblay, J.P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93, 586–599 (1994).
Karpati, G. et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 135, 27–32 (1989).
Kinoshita, I. et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17, 1407–1415 (1994).
Mendell, J.R. et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832–838 (1995).
Morgan, J.E., Hoffman, E.P. & Partridge, T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 111, 2437–2449 (1990).
Morgan, J.E., Pagel, C.N., Sherratt, T. & Partridge, T.A. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J. Neurol. Sci. 115, 191–200 (1993).
Morgan, J.E., Watt, D.J., Sloper, J.C. & Partridge, T.A. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J. Neurol. Sci. 86, 137–147 (1988).
Partridge, T.A. Invited review: myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 14, 197–212 (1991).
Petersen, Z.Q. & Huard, J. The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscles. Cell Transplant. 9, 503–517 (2000).
Qu, Z. et al. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142, 1257–1267 (1998).
Qu, Z. & Huard, J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther. 7, 428–437 (2000).
Tremblay, J.P. et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2, 99–112 (1993).
Vilquin, J.T., Wagner, E., Kinoshita, I., Roy, R. & Tremblay, J.P. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131, 975–988 (1995).
Lee, J.Y. et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell Biol. 150, 1085–1100 (2000).
Qu-Petersen, Z. et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157, 851–864 (2002).
Deasy, B.M., Schugar, R.C. & Huard, J. Sex differences in muscle-derived stem cells and skeletal muscle. Crit. Rev. Eukaryot. Gene Expr. 18, 173–188 (2008).
Payne, T.R. et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J. Am. Coll. Cardiol. 50, 1677–1684 (2007).
Corsi, K.A. et al. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J. Bone Miner. Res. 22, 1592–1602 (2007).
Lee, P.Y., Cobain, E., Huard, J. & Huang, L. Thermosensitive hydrogel PEG-PLGA-PEG enhances engraftment of muscle-derived stem cells and promotes healing in diabetic wound. Mol. Ther. 15, 1189–1194 (2007).
Kwon, D. et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 68, 449–454 (2006).
Oshima, H. et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol. Ther. 12, 1130–1141 (2005).
Chermansky, C.J. et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology 63, 780–785 (2004).
Cannon, T.W. et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 62, 958–963 (2003).
Cao, B. et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat. Cell Biol. 5, 640–646 (2003).
Li, Y. & Huard, J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am. J. Pathol. 161, 895–907 (2002).
Kuroda, R. et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum. 54, 433–442 (2006).
Lee, J.Y. et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum. Gene Ther. 13, 1201–1211 (2002).
Payne, T.R. et al. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther. 12, 1264–1274 (2005).
Deasy, B.M. et al. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J. Cell Biol. 177, 73–86 (2007).
Jankowski, R.J., Haluszczak, C., Trucco, M. & Huard, J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum. Gene Ther. 12, 619–628 (2001).
Asakura, A., Seale, P., Girgis-Gabardo, A. & Rudnicki, M.A. Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. 159, 123–134 (2002).
Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (in the press).
Zheng, B. et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol. 25, 1025–1034 (2007).
Jankowski, R.J., Deasy, B.M. & Huard, J. Muscle-derived stem cells. Gene Ther. 9, 642–647 (2002).
Rando, T.A. & Blau, H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125, 1275–1287 (1994).
Richler, C. & Yaffe, D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 23, 1–22 (1970).
Alessandri, G. et al. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364, 1872–1883 (2004).
Epperly, M.W. et al. Bone marrow origin of cells with capacity for homing and differentiation to esophageal squamous epithelium. Radiat. Res. 162, 233–240 (2004).
Hwang, J.H. et al. Isolation of muscle derived stem cells from rat and its smooth muscle differentiation [corrected]. Mol. Cells 17, 57–61 (2004).
Machida, S., Spangenburg, E.E. & Booth, F.W. Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages. Cell Prolif. 37, 267–277 (2004).
Rouger, K. et al. Progenitor cell isolation from muscle-derived cells based on adhesion properties. J. Histochem. Cytochem. 55, 607–618 (2007).
Sun, J.S., Wu, S.Y. & Lin, F.H. The role of muscle-derived stem cells in bone tissue engineering. Biomaterials 26, 3953–3960 (2005).
Huard, J., Cao, B. & Qu-Petersen, Z. Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res. 69, 230–237 (2003).
Peault, B. et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 15, 867–877 (2007).
Carr, L.K. et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int. Urogynecol. J. Pelvic. Floor Dysfunct. 19, 881–883 (2008).
Deasy, B.M., Jankowski, R.J. & Huard, J. Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells Mol. Dis. 27, 924–933 (2001).
Tavian, M. et al. The vascular wall as a source of stem cells. Ann. N Y Acad. Sci. 1044, 41–50 (2005).
Sarig, R., Baruchi, Z., Fuchs, O., Nudel, U. & Yaffe, D. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 24, 1769–1778 (2006).
Lu, A. et al. Isolation of myogenic progenitor populations from Pax7 deficient skeletal muscle based on adhesion characteristics. Gene Ther. (in the press).
Strober, W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. Appendix 3, Appendix 3B (2001).
Deasy, B.M. et al. Long-term self-renewal of postnatal muscle-derived stem cells. Mol. Biol. Cell 16, 3323–3333 (2005).
Romero-Ramos, M. et al. Neuronal differentiation of stem cells isolated from adult muscle. J. Neurosci. Res. 69, 894–907 (2002).
Winitsky, S.O. et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol. 3, e87 (2005).
Tamaki, T. et al. Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS ONE 3, e1789 (2008).
Arsic, N., Mamaeva, D., Lamb, N.J. & Fernandez, A. Muscle-derived stem cells isolated as non-adherent population give rise to cardiac, skeletal muscle and neural lineages. Exp. Cell Res. 314, 1266–1280 (2008).
Nolazco, G. et al. Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 101, 1156–1164 (2008).
Acknowledgements
This work was supported in part by the National Institutes of Health (R01HL069368-01A1 BRP; R01-49684), the US Department of Defense (W81XWH-05-01-0337) and the Muscular Dystrophy Association (J.H.). The Stem Cell Research Center receives financial support from the William F. and Jean W. Donaldson Endowed Chair at the Children's Hospital of Pittsburgh of UPMC and the Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Senior author (Johnny Huard) receives consultant fee and royalties related to a patent license for this technology to Cook MyoSite, Inc.
Rights and permissions
About this article
Cite this article
Gharaibeh, B., Lu, A., Tebbets, J. et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 3, 1501–1509 (2008). https://doi.org/10.1038/nprot.2008.142
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2008.142
This article is cited by
-
IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis
Oncogene (2023)
-
Sex-specific preservation of neuromuscular function and metabolism following systemic transplantation of multipotent adult stem cells in a murine model of progeria
GeroScience (2023)
-
Impact of fetal exposure to mycotoxins on longissimus muscle fiber hypertrophy and miRNA profile
BMC Genomics (2022)
-
The role of the aging microenvironment on the fate of PDGFRβ lineage cells in skeletal muscle repair
Stem Cell Research & Therapy (2022)
-
Bone morphogenetic protein 4 rescues the bone regenerative potential of old muscle-derived stem cells via regulation of cell cycle inhibitors
Stem Cell Research & Therapy (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.